Michael Ragosta, MD
Interventional Cardiology · Charlottesville, VANPI 1376609610
Payments from drug & device makers
Across 374 payments — averaging $2751.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$729K
- Medtronic$182K
- Biotronik Inc.$70K
- Livanova USA, Inc.$26K
- Corindus Inc.$6K
- Abbott$5K
- plus $11K from 9 others
What the payments were for
- Consulting fees$1,80011%
- Speaking & faculty fees$2,50015%
- Travel & lodging$9,20556%
- Food & beverage$3,02718%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 57 | $728,602 |
| Medtronic(2 entities) | 65 | $182,271 |
| Biotronik Inc. | 219 | $69,970 |
| Livanova USA, Inc. | 5 | $26,000 |
| Corindus Inc. | 1 | $5,600 |
| Abbott | 8 | $5,442 |
| Bayer | 2 | $3,849 |
| Cardiovascular Systems Inc. | 6 | $2,811 |
| Siemens Medical Solutions USA, Inc. | 2 | $2,516 |
| Ancora Heart, Inc. | 2 | $1,222 |
| Shockwave Medical, Inc | 1 | $286 |
| Verge Medical, Inc. | 1 | $215 |
| Edwards Lifesciences | 2 | $171 |
| Novo Nordisk | 1 | $116 |
| GE HealthCare | 2 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,029,122 in reported general payments places this provider in the 95th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 73 | $61,345 |
| Repatha SureclickEvolocumab | 21 | $25,613 |
| Praluent PenAlirocumab | 26 | $17,355 |
| Ranolazine ErRanolazine | 32 | $3,068 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $2,930 |
| Ezetimibe | 53 | $2,167 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 143 | $2,084 |
| Metoprolol Succinate | 145 | $1,565 |
| Atorvastatin Calcium | 151 | $1,303 |
| Prasugrel Hcl | 18 | $1,170 |
| ClopidogrelClopidogrel Bisulfate | 163 | $964 |
| Rosuvastatin Calcium | 73 | $759 |
| Lisinopril | 63 | $580 |
| Nitroglycerin | 49 | $499 |
| Amlodipine Besylate | 60 | $493 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Charlottesville
- John SaxonCharlottesville$900K
- Kanwar SinghCharlottesville$401K
- Angela TaylorCharlottesville$267K
- Saad GhummanCharlottesville$17K
- Deepak TalrejaVirginia Beach$2M
- Rajiv TayalFredericksburg$2M
- Jason FoerstRoanoke$956K
- Noah JonesFalls Church$907K
- Wayne BatchelorFalls Church$723K
- Matthew SummersNorfolk$614K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.